US Funds Moderna for Bird Flu Vaccine

13

For ads-free news, click here.

The U.S. government has announced a $176 million investment in Moderna to develop an mRNA-based vaccine aimed at combating a potential pandemic flu, specifically targeting bird flu in humans.

This initiative comes amid growing concerns over increasing cases of bird flu in dairy cows across the country.

The decision has sparked a range of reactions, with some expressing skepticism and criticism regarding the effectiveness and safety of mRNA vaccines, while others see it as a necessary step to prepare for potential health crises.

REACTIONS ONLINE

CLICK HERE FOR COMMENTS SECTION